94108 ⎘
Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring; Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring; Oxygen atoms in position 2
METHOD FOR ARYL DEBROMINATION AND ACYLATION OF BROMINATED BENZO-FUSED NITROGEN HETEROCYCLE
#2N-(BENZHYDRYL)CYCLOALKYLCARBOXAMIDE DERIVATIVES AS INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOF
#3CARBONIC ANHYDRASE ENZYME INHIBITORS AND METHODS OF USE THEREOF
#4TPK AGONIST AND METHOD FOR USING SAME TO TREAT NEURODEGENERATIVE DISEASES
#5INDOLINONE COMPOUNDS AND USES THEREOF
#6SULFONYL DERIVATIVES AS CCR6 INHIBITORS
#7CYCLOALKYL CARBOXYLIC ACID DERIVATIVES AS INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOF
#8HSD17B13 INHIBITORS AND USES THEREOF
#9Modulators of BCL6 as Ligand Directed Degraders
#10BICYCLE COMPOUNDS AS TEAD INHIBITOR
#11ALKYLAMINE OR HETEROALKYLAMINE DERIVATIVES AS INHIBITORS OF NITRIC OXIDE SYNTHASES (NOS), PHARMACEUTICAL PRODUCTS THEREOF, AND METHODS THEREOF
#12TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA
#13ACRYLAMIDE COMPOUNDS
#14ALLOSTERIC STING MODULATORS AND METHODS OF USE
#15INDOLINONE DERIVATIVES AS INHIBITORS OF MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE
#16MODIFIED REDOX-ACTIVE SORBENTS FOR ELECTROCHEMICAL CARBON DIOXIDE SEPARATION
#17COMPOUNDS FOR TREATING POLYQ-RELATED NEURODEGENERATIVE DISORDERS
#18GLUN2B-SUBUNIT SELECTIVE ANTAGONISTS OF THE N-METHYL-D-ASPARTATE RECEPTORS WITH ENHANCED POTENCY AT ACIDIC PH
#19NOVEL COMPOUNDS
#20OXOINDOLINYL AMIDE DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOF
#21GLUN2B-SUBUNIT SELECTIVE ANTAGONISTS OF THE N-METHYL-D-ASPARTATE RECEPTORS WITH ENHANCED POTENCY AT ACIDIC PH
#22MAXI-K POTASSIUM CHANNEL OPENERS FOR THE TREATMENT OF FRAGILE X ASSOCIATED DISORDERS
#2314-3-3 PROTEIN MODULATORS AS ANTITUMOR AGENTS
#24BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME
#25Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
#26ULK INHIBITORS AND METHODS OF USE THEREOF
#27N-(BENZOYL)-PHENYLALANINE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF
#28INHIBITORS OF MYCOBACTERIUM TUBERCULOSIS LIPOAMIDE DEHYDROGENASE
#291,3-CYCLOHEXANEDIONE DERIVATIVES AND 1,3-CYCLOPENTANEDIONE DERIVATIVES AS BUFFERING MOLECULES IN NON-AQUEOUS SOLUTIONS
#30ARYL ETHER COMPOUNDS AS TEAD MODULATORS
#31MODIFIED ISOINDOLINONES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS
#32NOVEL COMPOUNDS
#33AN IMPROVED HIGHLY EFFICIENT PROCESS FOR THE PREPARATION OF NINTEDANIB AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
#34Modulators of BCL6 as Ligand Directed Degraders
#35ANTICANCER COMPOUNDS SELECTIVE FOR ER-POSITIVE CANCERS
#36MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
#37TRUXILLIC ACID MONOESTER-DERIVATIVES AS SELECTIVE FABP5 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
#38INHIBITORS OF NITRIC OXIDE SYNTHASES (NOS), PHARMACEUTICAL PRODUCTS THEREOF, AND METHODS THEREOF
#39COMPOSITION FOR FORMING ORGANIC FILM, PATTERNING PROCESS, AND COMPOUND AND POLYMER FOR FORMING ORGANIC FILM
#40SOX11 INHIBITORS FOR TREATING MANTLE CELL LYMPHOMA
#41SMALL MOLECULE INHIBITORS OF GRK5 AND GRK5 SUBFAMILY MEMBERS AND USES THEREOF
#42COMPOUND AS A UBR BOX DOMAIN LIGAND
#43COMPOUND AS A UBR BOX DOMAIN LIGAND
#44COMPOSITION FOR FORMING ORGANIC FILM, PATTERNING PROCESS, AND COMPOUND AND POLYMER FOR FORMING ORGANIC FILM
#45DEGRADATION OF PROTEIN KINASES BY CONJUGATION OF PROTEIN KINASE INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE
#462-oxindole compounds
#47Salts of Nintedanib and Crystalline Forms Thereof
#48Methods and compounds for restoring mutant p53 function
#49Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
#50Ion channel antagonists/blockers and uses thereof
#51INDOLINONE COMPOUNDS FOR USE AS MAP4K1 INHIBITORS
#52ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF
#53ANTI-FIBROTIC COMPOUNDS AND USE THEREOF
#54Compounds
#55INHIBITORS OF TYROSINE KINASE
#56INDOLINONE COMPOUNDS AND USES THEREOF
#57SMALL MOLECULE GRB2 STABILIZERS FOR RAS MAP KINASE INHIBITION
#58METHOD FOR INTRODUCING DEUTERATED LOWER ALKYL INTO AMINE MOIETY OF COMPOUND CONTAINING SECONDARY AMINE
#59HDAC1,2 inhibitors
#60Orally available sEH/PDE4 dual inhibitors
#61[1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitors
#62COMPOUND AND PREPARATION METHOD AND APPLICATION THEREOF
#63Modulators of mas-related g-protein receptor X4 and related products and methods
#64Activators of the unfolded protein response
#65COMPOSITIONS AND METHODS FOR SUPPRESSING AND/OR TREATING A GROWTH RELATED DISEASE AND/OR A CLINICAL CONDITION THEREOF
#66Antiviral compounds
#67INDOLINONE DERIVATIVES AS INHIBITORS OF MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE
#68Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α
#69Ammonium salts of 3-(3,5-dibromo-4-hydroxybenzyliden)-5-indo-1,3-dihydroindol-2-one and uses thereof
#70NOVEL COMPOUNDS
#71Activators of the unfolded protein response
#72Opioid receptor modulators and products and methods related thereto
#73Compositions for the treatment of pulmonary fibrosis
#74Indole derivatives and their use as protein kinase inhibitors
#752-oxindole compounds
#76Reagents and methods for analysis of proteins and metabolites targeted by covalent probes
#77Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use
#78Methods and compositions associated with the granulocyte colony-stimulating factor receptor
#79BINDING FUNCTION 3 (BF3) SITE COMPOUNDS AS THERAPEUTICS AND METHODS FOR THEIR USE
#80Method for producing lactam compound, and lactam compound produced thereby
#81MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
#82Synthesis of 2-indolinone derivatives
#83PPAR agonists and methods of use thereof
#84COMPOSITIONS AND METHODS TO IMPROVE THE THERAPEUTIC BENEFIT OF INDIRUBIN AND ANALOGS THEREOF, INCLUDING MEISOINDIGO
#85Activators of the unfolded protein response
#86PPAR agonists
#87HETEROCYCLIC SMALL MOLECULE MODULATORS OF HUMAN STING
#88Method for purifying ropinirole hydrochloride
#89Antiproliferative compounds and methods of use thereof
#902-oxindole compounds
#91Histone acetyltransferase activators and uses thereof
#92Methods for preparing Nintedanib and intermediates thereof
#93Therapeutic heterocyclic compounds
#94Polymer-semaxanib moiety conjugates
#95Indolinone derivatives as inhibitors of maternal embryonic leucine zipper kinase
#96Reagents and methods for analysis of proteins and metabolites targeted by covalent probes
#97Indoline analogs and uses thereof
#98Indolinones compounds and their use in the treatment of fibrotic diseases
#99HIGH HEAT MONOMERS AND METHODS OF USE THEREOF
#100Binding Function 3 (BF3) site compounds as therapeutics and methods for their use
#101POLYMORPH OF NINTEDANIB
#102Compositions for the treatment of pulmonary fibrosis
#103Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use
#104Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (T))
#105Anti-fibrotic pyridinones
#106Benzimidazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (T))
#107Indole derivatives and their use as protein kinase inhibitors
#108Crystalline modifications of methyl (3Z)-3-{[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}phenyl)amino](phenyl)methylidene}-2-oxo-2,3-dihydro-1H-indole-6-carboxylate salts and methods of preparation thereof
#109Bisphenol compound and aromatic polycarbonate
#110MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DEISEASES
#1112-oxindole compounds
#112Methods and compositions associated with the granulocyte colony-stimulating factor receptor
#113Histone Acetyltransferase Activators and Uses Thereof
#114Oxindoles derivatives, preparation method thereof and pharmaceutical compositions for the prevention or treatment of cancer containing the same as an active ingredient
#115PPAR agonists and methods of use thereof
#116Inhibitors of KRAS G12C mutant proteins
#117Tetrahydroquinoline sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (t))
#118INDOLINONE COMPOUNDS AND USES THEREOF
#119ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF
#120Polymer-semaxanib moiety conjugates
#121PPAR agonists
#122INDOLE AND AZAINDOLE DERIVATIVE HAVING AMPK-ACTIVATING ACTIVITY
#123Oxindole compounds and pharmaceutical compositions thereof
#124C5, C6 substituted and/or fused oxindoles as anti-cancer agents and process for preparation thereof
#125Indolone compounds and their use as AMPA receptor modulators
#126Nintedanib diethanesulfonate salt crystal and preparation method and use thereof
#127Selective HDAC1 and HDAC2 inhibitors
#128Antiproliferative compounds and methods of use thereof
#129Bis(sulfonamide) derivatives and their use as mPGES inhibitors
#130TAK1 kinase inhibitors, compositions, and uses related thereto
#131Indoline analogs and uses thereof
#132Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR γ (T))
#133PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITORS AND METHODS OF USE THEREOF
#134Indoline analogs and uses thereof
#135Pharmaceutical dosage form for immediate release of an indolinone derivative
#136Indole-derived compound production
#137Selective HDAC3 inhibitors
#1382-OXINDOLE COMPOUNDS
#139HISTONE ACETYLTRANSFERASE ACTIVATORS AND USES THEREOF
#140Preparation method of Nintedanib
#141High heat monomers and methods of use thereof
#142TRPV1 vanilloid receptor antagonists with a bicyclic portion
#143Method for the synthesis of solid heterogeneous chiral catalysts and their use in stereoselective reactions
#144OPSIN-BINDING LIGANDS, COMPOSITIONS AND METHODS OF USE
#145Anti-fibrotic pyridinones
#146Organic semiconducting compounds
#147Indolinone compounds and uses thereof
#148Indolinone compounds and uses thereof
#149Selective HDAC1 and HDAC2 inhibitors
#150NITRIFICATION INHIBITORS
#151Binding function (BF) site compounds as therapeutics and methods for their use
#152Method for producing optically active carboxylic acid ester
#153Antiproliferative compounds and methods of use thereof
#154Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists
#155Methods and compositions associated with the granulocyte colony-stimulating factor receptor
#156OLEFIN SUBSTITUTED OXINDOLES HAVING AMPK ACTIVITY
#157Pharmaceutical compound
#158Oxindole derivatives, preparation thereof and therapeutic use in the treatment of AMPK-related diseases
#159Compositions for the treatment of hypertension and/or fibrosis
#160Phosphine ligands for catalytic reactions
#161OXINDOLE INHIBITORS OF TYROSINE KINASE
#162Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo
#163Use of substituted dihydrooxindolylsulfonamides, or the salts thereof, for increasing the stress tolerance of plants
#164Aurora kinase inhibitors
#165GLYCINE TRANSPORTER INHIBITOR
#1663-(2-amino-ethyl)-alkylidene)-thiazolidine-2,4-dione and 1-(2-amino-ethyl)-alkylidene-1,3-dihydro-indol-2-one derivatives as selective sphingosine kinase 2 inhibitors
#167Methods and compositions for treating Ewings sarcoma family of tumors
#168Substance having tyrosine kinase inhibitory activity and preparation method and use thereof
#169Medicaments for the treatment or prevention of fibrotic diseases
#1701,3-diaminocyclopentane carboxamide derivatives
#171Indolinone compounds and uses thereof
#172PPAR agonists
#173Antiproliferative compounds and methods of use thereof
#174Compound with branching alkyl chains, method for preparing the same, and use thereof in photoelectric device
#175Albicidin derivatives, their use and synthesis
#176Inhibitors of beta-catenin in treatment of colorectal cancer
#177Phosphine ligands for catalytic reactions
#178Synthesis of N-derivatized lactam based ionic liquid
#179Plasminogen activator inhibitor-1 inhibitors and methods of use thereof
#180Indolinone derivative as tyrosine kinase inhibitor
#181Amine derivative or salt thereof
#182Selective HDAC3 inhibitors
#183Compound; tautomer and geometric isomer thereof; salt of said compound, tautomer, or geometric isomer; method for manufacturing said compound, tautomer, isomer, or salt; antimicrobial agent; and anti-infective drug
#1847-substituted indole Mcl-1 inhibitors
#185OXINDOLE INHIBITORS OF TYROSINE KINASE
#186Oxindole compounds and compositions comprising the same
#187Hematopoietic growth factor mimetic small molecule compounds and their uses
#188Aurora kinase inhibitors
#189Isatin compounds, compositions and methods for treatment of degenerative diseases and disorders
#190Substituted 2,2′-biphenazines for treating diseases
#191Continuous method for producing ortho-substituted anilines in a flow reactor
#192Indole and azaindole derivative having AMPK-activating activity
#193Activators of human pyruvate kinase
#194Phosphine ligands for catalytic reactions
#195Estrogen receptor modulators and uses thereof
#196Methods and compositions for treating Ewings sarcoma family of tumors
#197Chemical process for preparing spiroindolones and intermediates thereof
#198Method of using an indolinone molecule and derivatives for inhibiting liver fibrosis and hepatitis
#199Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists
#200Phosphine ligands for catalytic reactions
#201Substituted piperidinyl-carboxamide derivatives useful as SCD 1 inhibitors
#202EP1 receptor ligands
#203Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
#204Methods and compositions associated with the granulocyte colony-stimulating factor receptor
#205MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
#206Novel Alkene Oxindole Derivatives
#207Isatin compounds, compositions and methods for treatment of degenerative diseases and disorders
#208Opsin-binding ligands, compositions and methods of use
#209TAK1 kinase inhibitors, compositions, and used related thereto
#210Selective HDAC3 inhibitors
#211Selective HDAC3 inhibitors
#212Compositions for the treatment of Fragile X syndrome
#213MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
#214N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease
#215Process for preparing 6-iodo-2-oxindole
#2167-substituted indole Mcl-1 inhibitors
#217NMDA receptor antagonists for neuroprotection
#218Stable laquinimod preparations
#219Anticancer compounds
#220CRYSTALLINE FORM OF A INDOLINONE DERIVATIVE AND ITS USE
#221Compound with branching alkyl chains, method for preparing the same, and use thereof in photoelectric device
#222Polymer-semaxanib moiety conjugates
#223Thionating agent
#224Kappa opioid receptor agonists
#225Process for the preparation of oxindoles and ortho-substituted anilines and their use as intermediates for syntheses
#226Cyclopropanecarboxylate esters of purine analogues
#227Indolin-2-one derivatives as protein kinase inhibitors
#228Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents
#229Phosphine ligands for catalytic reactions
#230Compositions and methods for treatment of neurodegenerative disease
#231Indirubin derivatives and uses thereof in treating chronic myelogenous leukemia
#232Alkene oxindole derivatives
#233ACTIVATORS OF HUMAN PYRUVATE KINASE
#234Thionation process and a thionating agent
#235TRPV1 vanilloid receptor antagonists with a bicyclic portion
#236Benzylidene-indolinone compounds and their medical use
#237Cyanate ester compounds and cured products thereof
#238Compounds which have activity at Mreceptor and their uses in medicine
#239Piperidine and piperazine derivatives
#240Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
#241Hematopoietic growth factor mimetic small molecule compounds and their uses
#242INDOLINE DERIVATIVES AND THEIR USE IN TREATING DISEASE-STATES SUCH AS CANCER
#243PROCESS FOR THE PREPARATION OF ROPINIROLE AND SALTS THEREOF
#2442,2′-biphenazine compounds and methods useful for treating disease
#245Stable laquinimod preparations
#246Quinone compounds as dopants in organic electronics
#247Novel Compounds 621
#248COMPOUND INHIBITING IN VIVO PHOSPHORUS TRANSPORT AND MEDICINE CONTAINING THE SAME
#249OPTICALLY ACTIVE 3-[(PHENYLPIPERAZIN-1-YL)ALKYL]-3- ALKYL-OXINDOLE DERIVATIVES HAVING CNS ACTIVITY
#2503-3-di-substituted-oxindoles as inhibitors of translation initiation
#251Carboxy isatin hydrazones and their esters as Shp2 inhibitors
#252Phosphine ligands for catalytic reactions
#253MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
#254Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
#255Substituted phenylpiperazinyl aralkylalcohol derivatives, pharmaceutical compositions containing such derivatives and uses thereof
#256Process for preparing substituted 1,3-dihydro-2H-indol-2-ones
#257Preparation of 3-Pyrrole Substituted 2-Indolinone Derivatives
#258NOVEL BENZYLIDENE-INDOLINONE AND THEIR MEDICAL AND DIAGNOSTIC USES
#259Compounds
#260Substituted oxindole derivatives and medicaments containing the same
#261PIPERAZINE DERIVATIVES
#262Aryl guanidine FF-ATPase inhibitors and related methods
#263Process for the manufacture of an indolinone derivative
#264CYCLOHEXYL AMIDE DERIVATIVES AS CRF RECEPTOR ANTAGONISTS
#265NITROGEN-CONTAINING HETEROCYCLE DERIVATIVES SUBSTITUTED WITH CYCLIC GROUP
#266Cyclopropane indolinone derivatives
#267Heterocyclic amide derivatives as EP4 receptor antagonists
#268Oxindolyl inhibitor compounds
#269SALT FORMS OF A 6-FLUORO-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE DERIVATIVE, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
#270Process for the preparation of oxindoles and ortho-substituted anilines and their use as intermediates for syntheses
#271Bicyclic androgen and progesterone receptor modulator compounds and methods
#272Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
#273NOVEL ALKENE OXINDOLE DERIVATIVES
#2743-aminoalkyl-1,3-dihydro-2H-indol-2-one derivatives, preparation thereof and therapeutic use thereof
#275Substituted spiro[cycloalkyl-1,3′-indo]-2′(1′H)-one derivatives and their use as P38 mitogen-activated kinase inhibitors
#2763-3-di-substituted-oxindoles as inhibitors of translation initiation
#277Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
#278Ruthenium Catalysts and Uses Thereof
#279INDOLINONE COMPOUND
#280Metabotropic glutamate-receptor-potentiating isoindolones
#281Indolinone derivatives and process for their manufacture
#282Salts of perindopril
#283TETRAHYDRONAPHTHALENE DERIVATES, PROCESS FOR PREPARING THEM AND THEIR USE AS ANTIINFLAMMATORY AGENTS
#284DICARBONYL DERIVATIVES AND METHODS OF USE
#285Inflammatory cytokine release inhibitor
#286INTEGRIN EXPRESSION INHIBITOR
#2873-3-di-substituted-oxindoles as inhibitors of translation initiation
#288Process for the purification of Ropinirole hydrochloride
#2893-3-di-substituted-oxindoles as inhibitors of translation initiation
#290Morpholine derivative
#291SUBSTITUTED 3-(4-HYDROXYPHENYL)-INDOLIN-2-ONE COMPOUNDS
#292Piperidine and piperazine derivatives
#293BENZIMIDAZOLIDINONE DERIVATIVES AS MUSCARINIC AGENTS
#294Compounds which have activity at Mreceptor and their uses in medicine
#295Heterocyclic modulators of cannabinoid receptors
#296MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
#297OXINDOLES AS KINASE INHIBITORS
#298Indolin-2-ones and aza-indolin-2-ones
#299Compounds for the treatment of inflammatory diseases
#300INDOLINE DERIVATIVES AND THEIR USE IN TREATING DISEASE-STATES SUCH AS CANCER